Serious adverse events occurring during clinical trials: a French university hospital promotor experience

被引：0
|
作者：
Llau, M. E.
Roques, N.
Cantagrel, A.
Montastruc, J. L.
机构：
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2007年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
346
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [1] Serious adverse events in healthy volunteers identified during clinical trials
    Coimbra Hurtado, Jimena
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 48 - 48
  • [2] Serious adverse events and compensation in registration trials: A review of data from a Japanese university hospital
    Watanabe M.
    Tajima S.
    Katashima R.
    Miyamoto T.
    Yamagami M.
    Minakuchi K.
    Yanagawa H.
    [J]. BMC Research Notes, 7 (1)
  • [3] Serious adverse events in clinical trials with TAVR and SAVR
    Barth, U.
    [J]. HERZ, 2019, 44 (06) : 526 - 533
  • [4] Sources of Disagreement between Investigator and Sponsor in Causality Assessment of Serious Adverse Events during Academic French Clinical Trials
    Bezin, J.
    Miremont-Salame, G.
    Razafimanantsoa, M.
    Salvo, F.
    Moore, N.
    Haramburu, F.
    Gimbert, A.
    [J]. DRUG SAFETY, 2014, 37 (10) : 851 - 851
  • [5] Modeling an IT Support for Handling Serious Adverse Events in Clinical Trials
    Fonck, Simon
    Deserno, Thomas
    [J]. MEDINFO 2017: PRECISION HEALTHCARE THROUGH INFORMATICS, 2017, 245 : 1262 - 1262
  • [6] A call for improved reporting on serious adverse events in clinical trials
    Schutte, Aletta E.
    [J]. JOURNAL OF HYPERTENSION, 2019, 37 (11) : 2154 - 2155
  • [7] Complications of hypothermia: Interpreting 'serious,' 'adverse,' and 'events' in clinical trials
    de Toledo, Joan Sanchez
    Bell, Michael J.
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2010, 11 (03) : 439 - 441
  • [8] Clinical trials facing "Serious Adverse Events" during the ongoing COVID-19 pandemic
    Parikh, Purvish M.
    Mehta, Prashant
    Krishna Kumar MVT
    Govind Babu, K.
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (03) : 295 - 298
  • [9] SURVEILLANCE OF ADVERSE EVENTS AND SERIOUS ADVERSE EVENTS DURING VACCINE TRIAL: EXPERIENCE OF CVD MALI
    Doumbia, Moussa
    Haidara, Fadima Cheick
    Diallo, Fatoumata
    Coulibaly, Flanon
    Coulibaly, Adama
    Tapia, Milagritos D.
    Sow, Samba O.
    Kotloff, Karen
    Levine, Myron M.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 362 - 362
  • [10] Quality of serious adverse events reported to an academic sponsor of clinical trials
    Crepin, S.
    Villeneuve, C.
    Favier, R.
    Merle, L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 65 - 65
12345